Aim Recurrence of hepatocellular carcinoma (HCC) is observed frequently, even after
curative treatments. The aim of this study is to elucidate the risk factors for recurrence of …

Objective To determine the survival outcome and prognostic factors of hepatocellular
carcinoma (HCC) survival in patients who underwent radiofrequency ablation (RFA) …

AIMS: To evaluate the clinical inference of serum alpha-fetoprotein (AFP) response in
hepatocellular carcinoma (HCC) patients undergoing percutaneous radiofrequency ablation …

Abstract Background and Aim: To assess the significance of adequate α‐fetoprotein
decrease in monitoring the treatment effects of radiofrequency ablation (RFA) in …

Abstract Background and Aim The performance of alpha‐fetoprotein (AFP) in the detection
of hepatocellular carcinoma (HCC) recurrence after radiofrequency ablation was analyzed …

Aim Survival estimates are commonly reported as survival from the first observation, but
future survival probability changes based on the survival time already accumulated after …

Objective Percutaneous radiofrequency ablation (RFA) is one of the first-line curative
therapies for hepatocellular carcinoma (HCC), but factors affecting the prognosis remain …

Objective To define an optimal cutoff time to distinguish early and late recurrence in
hepatocellular carcinoma (HCC) patients after radiofrequency ablation (RFA), and to …

Objective This study aims to determine the risk factors, patterns, and long-term survival
outcomes of late recurrence after radiofrequency ablation (RFA) for hepatocellular …

Radiofrequency ablation (RFA) is an effective local treatment for curative intent in patients
with cirrhosis of the liver and hepatocellular carcinoma (HCC) with diameter< 3 cm. Several …